Sort
40,608 grants matching “prostate cancer”
Targeted Fluorescence Imaging of Nerves for Surgical Guidance
$921,280Cristina A Tan Hehir · General Electric Global Research Ctr · R01 · FY2010 · EB
A Novel Optical Spectral Imaging System for Rapid Imaging of Breast Tumor Margins
$920,632Nimmi Ramanujam · Duke University · R01 · FY2014 · EB
Project 3: Integrative and Functional Genomics of Aggressive Prostate Cancer in African American Men
$920,413John David Carpten · University Of Southern California · U19 · FY2022 · CA
THE ROLE OF ANDROGEN DEPRIVATION THERAPY IN DEPRESSION IN PATIENTS WITH PROSTATE CANCER: A LONGITUDINAL STUDY (RADICAL)
$920,262Mcmaster University · · FY2025 · Defense Health Agency
METABOLIC TARGETING OF SKP2 EXPRESSION AS A NOVEL THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
$920,250Augusta University Research Institute, Inc · · FY2019 · Department of the Army
TARGETING NOVEL GDF15/GFRAL/RET AXIS IN PROSTATE CANCER BONE METASTASIS.
$920,058Board Of Regents Of The University Of Nebraska · · FY2021 · Defense Health Agency
CD133-TARGETED NATURAL KILLER CELL THERAPY FOR AGGRESSIVE PROSTATE CANCER
$920,007University Of Wisconsin System · · FY2019 · Department of the Army
Radiation-induced translational control of gene expression
$919,974Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Diazeniumdiolates as Broad-Spectrum Anticancer Agents
$919,966Larry K Keefer · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Defining the Importance of Immunity to NY-ESO-1 in Melanoma Therapy and Prognosis
$918,701Jedd D. Wolchok · Sloan-Kettering Inst Can Research · RC2 · FY2009 · CA
CANCER AND LEUKEMIA GROUP B
$918,123Brigham And Women'S Hospital · U10 · FY2002 · CA
COMBINING TARGETED RADIONUCLIDE THERAPY AND EPIGENETIC REGULATORS FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER.
$918,014University Of Wisconsin System · · FY2021 · Defense Health Agency
Clinical Cancer Genomics Program
$917,710Kathleen Calzone · Division Of Basic Sciences - Nci · ZID · FY2021 · CA
DECONVOLUTE KEY BIOLOGICAL DRIVERS THAT DEFINE SUBSETS OF LETHAL PROSTATE CANCER IN AFRICAN AMERICAN MEN
$917,307H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · · FY2025 · Defense Health Agency
Tissue Processing-Sequencing Facility
$917,291Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Stroger Hospital of Cook County (SHCC) NCORP
$916,936Deimante Tamkus · Cook County Health And Hospital System · UG1 · FY2025 · CA
Molecular Biology, Regulation, And Biochemistry of UDP-glucuronosyltransferases.
$916,866Ida S Owens · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
$916,536Brian E Henderson · University Of Southern California · U01 · FY2007 · CA
Biological Functions of Chromosomal Proteins
$916,515Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
ROCKY MOUNTAIN CANCER GENETICS COALITION
$916,477University Of Utah · U24 · FY2001 · CA
Prostate Cancer Studies
$915,981Ann Hsing · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities
$915,360Craig M Crews · Yale University · R35 · FY2024 · CA
Modeling and analytics for cancer diagnostics: traversing the data-evidence divide
$915,181Ruth D Etzioni · Fred Hutchinson Cancer Center · R35 · FY2024 · CA
A NOVEL CLASS OF GALECTIN-1 INHIBITORS FOR PROSTATE CANCER THERAPY
$915,156University Of California, Davis · · FY2019 · Defense Health Agency
A Genome-wide Association Study of Prostate Cancer in African Americans
$915,027Brian E Henderson · University Of Southern California · U01 · FY2010 · CA